160 related articles for article (PubMed ID: 19695223)
1. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
Yun J; Kim YI; Tomida A; Choi CH
Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
[TBL] [Abstract][Full Text] [Related]
2. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
Yun J; Tomida A; Andoh T; Tsuruo T
J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
[TBL] [Abstract][Full Text] [Related]
3. Smurf2-Mediated Stabilization of DNA Topoisomerase IIα Controls Genomic Integrity.
Emanuelli A; Borroni AP; Apel-Sarid L; Shah PA; Ayyathan DM; Koganti P; Levy-Cohen G; Blank M
Cancer Res; 2017 Aug; 77(16):4217-4227. PubMed ID: 28611047
[TBL] [Abstract][Full Text] [Related]
4. Identification of Elongin C and Skp1 sequences that determine Cullin selection.
Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW
J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393
[TBL] [Abstract][Full Text] [Related]
5. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
[TBL] [Abstract][Full Text] [Related]
6. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
7. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
Singh R; Winn LM
Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
[TBL] [Abstract][Full Text] [Related]
9. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer.
Liu X; Zurlo G; Zhang Q
Adv Exp Med Biol; 2020; 1217():173-186. PubMed ID: 31898228
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3.
Mo YY; Wang Q; Beck WT
Cancer Res; 1997 Nov; 57(22):5004-8. PubMed ID: 9371492
[TBL] [Abstract][Full Text] [Related]
12. Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.
Brower CS; Sato S; Tomomori-Sato C; Kamura T; Pause A; Stearman R; Klausner RD; Malik S; Lane WS; Sorokina I; Roeder RG; Conaway JW; Conaway RC
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10353-8. PubMed ID: 12149480
[TBL] [Abstract][Full Text] [Related]
13. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
14. Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.
Sufan RI; Ohh M
Neoplasia; 2006 Nov; 8(11):956-63. PubMed ID: 17132228
[TBL] [Abstract][Full Text] [Related]
15. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.
Pause A; Peterson B; Schaffar G; Stearman R; Klausner RD
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9533-8. PubMed ID: 10449727
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.
Stros M; Bacíková A; Polanská E; Stokrová J; Strauss F
Nucleic Acids Res; 2007; 35(15):5001-13. PubMed ID: 17636313
[TBL] [Abstract][Full Text] [Related]
18. Proteomic dissection of the von Hippel-Lindau (VHL) interactome.
Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of the von Hippel-Lindau-like protein.
Qi H; Gervais ML; Li W; DeCaprio JA; Challis JR; Ohh M
Mol Cancer Res; 2004 Jan; 2(1):43-52. PubMed ID: 14757845
[TBL] [Abstract][Full Text] [Related]
20. NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL.
Russell RC; Ohh M
EMBO Rep; 2008 May; 9(5):486-91. PubMed ID: 18323857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
